Status:
RECRUITING
AI-Driven Early Detection of Skin Cancer
Lead Sponsor:
Nuvana Healthcare LTD
Collaborating Sponsors:
National Institute for Health Research, United Kingdom
Conditions:
Skin Cancer Melanoma
Eligibility:
All Genders
18+ years
Brief Summary
This study evaluates the feasibility and accuracy of an AI-powered mobile platform (NuvanaDx) for early detection of skin cancer, including melanoma, using smartphone-based imaging. The platform is de...
Detailed Description
The study will collect retrospective and prospective anonymized skin lesion images and metadata to validate the AI algorithm against dermatology-confirmed diagnoses. The aim is to determine sensitivit...
Eligibility Criteria
Inclusion
- Adults (≥18 years) presenting with skin lesions suspicious for malignancy.
- Ability to provide informed consent.
Exclusion
- Inability to provide informed consent.
- Poor-quality images unsuitable for AI analysis.
Key Trial Info
Start Date :
October 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT07144306
Start Date
October 1 2025
End Date
January 1 2026
Last Update
September 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nuvana Healthcare Ltd
London, United Kingdom